1. Home
  2. ACTU vs MRT Comparison

ACTU vs MRT Comparison

Compare ACTU & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • MRT
  • Stock Information
  • Founded
  • ACTU 2015
  • MRT 2018
  • Country
  • ACTU United States
  • MRT Turkey
  • Employees
  • ACTU N/A
  • MRT N/A
  • Industry
  • ACTU
  • MRT Rental/Leasing Companies
  • Sector
  • ACTU
  • MRT Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • MRT Nasdaq
  • Market Cap
  • ACTU 162.1M
  • MRT 181.8M
  • IPO Year
  • ACTU 2024
  • MRT N/A
  • Fundamental
  • Price
  • ACTU $7.69
  • MRT $3.45
  • Analyst Decision
  • ACTU
  • MRT
  • Analyst Count
  • ACTU 0
  • MRT 0
  • Target Price
  • ACTU N/A
  • MRT N/A
  • AVG Volume (30 Days)
  • ACTU 20.8K
  • MRT 41.3K
  • Earning Date
  • ACTU 03-04-2025
  • MRT 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • MRT N/A
  • EPS Growth
  • ACTU N/A
  • MRT N/A
  • EPS
  • ACTU N/A
  • MRT N/A
  • Revenue
  • ACTU N/A
  • MRT $18,953,502.00
  • Revenue This Year
  • ACTU N/A
  • MRT N/A
  • Revenue Next Year
  • ACTU N/A
  • MRT $101.81
  • P/E Ratio
  • ACTU N/A
  • MRT N/A
  • Revenue Growth
  • ACTU N/A
  • MRT N/A
  • 52 Week Low
  • ACTU $5.51
  • MRT $0.71
  • 52 Week High
  • ACTU $11.73
  • MRT $3.89
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • MRT 55.09
  • Support Level
  • ACTU N/A
  • MRT $2.86
  • Resistance Level
  • ACTU N/A
  • MRT $3.70
  • Average True Range (ATR)
  • ACTU 0.00
  • MRT 0.23
  • MACD
  • ACTU 0.00
  • MRT 0.03
  • Stochastic Oscillator
  • ACTU 0.00
  • MRT 70.36

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About MRT Marti Technologies Inc.

Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.

Share on Social Networks: